Platelet function testing in atrial fibrillation patients undergoing percutaneous coronary intervention
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-742X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Platelet function testing in atrial fibrillation patients undergoing percutaneous coronary intervention ; day:12 ; month:11 ; year:2022 ; pages:1-9
Journal of thrombosis and thrombolysis ; (12.11.2022), 1-9
- Urheber
-
Lianos, Ioannis
Varlamos, Charalampos
Benetou, Despoina-Rafailia
Mantis, Christos
Kintis, Konstantinos
Dragona, Vassiliki-Maria
Kanakakis, Ioannis
Sionis, Dimitrios
Patsilinakos, Sotirios
Alexopoulos, Dimitrios
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11239-022-02723-4
- URN
-
urn:nbn:de:101:1-2023012620593575639492
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lianos, Ioannis
- Varlamos, Charalampos
- Benetou, Despoina-Rafailia
- Mantis, Christos
- Kintis, Konstantinos
- Dragona, Vassiliki-Maria
- Kanakakis, Ioannis
- Sionis, Dimitrios
- Patsilinakos, Sotirios
- Alexopoulos, Dimitrios
- SpringerLink (Online service)
Ähnliche Objekte (12)
Low on-clopidogrel ADP- and TRAP-6-induced platelet aggregation in patients with atrial fibrillation undergoing percutaneous coronary intervention: an observational pilot study
Low on-clopidogrel ADP- and TRAP-6-induced platelet aggregation in patients with atrial fibrillation undergoing percutaneous coronary intervention: an observational pilot study
Left atrial appendage closure in nonvalvular atrial fibrillation patients with percutaneous coronary intervention
Optimal antithrombotic treatment of patients with atrial fibrillation undergoing percutaneous coronary intervention: triple therapy is too much!
Novel Dual Therapy: A Paradigm Shift in Anticoagulation in Patients of Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
Antithrombotic treatment in atrial fibrillation patients needing percutaneous coronary intervention
Atrial fibrillation
Meta-Analysis Comparing Potent Oral P2Y12 Inhibitors versus Clopidogrel in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
The WOEST 2 registry : A prospective registry on antithrombotic therapy in atrial fibrillation patients undergoing percutaneous coronary intervention
How cardiologists manage antithrombotic treatment of patients with atrial fibrillation undergoing percutaneous coronary stenting: the WOEST survey 2018
Anti-thrombotic strategies in patients with atrial fibrillation undergoing PCI
Atrial remodeling in atrial fibrillation and association between microRNA network and atrial fibrillation
Low on-clopidogrel ADP- and TRAP-6-induced platelet aggregation in patients with atrial fibrillation undergoing percutaneous coronary intervention: an observational pilot study
Low on-clopidogrel ADP- and TRAP-6-induced platelet aggregation in patients with atrial fibrillation undergoing percutaneous coronary intervention: an observational pilot study
Left atrial appendage closure in nonvalvular atrial fibrillation patients with percutaneous coronary intervention
Optimal antithrombotic treatment of patients with atrial fibrillation undergoing percutaneous coronary intervention: triple therapy is too much!
Novel Dual Therapy: A Paradigm Shift in Anticoagulation in Patients of Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
Antithrombotic treatment in atrial fibrillation patients needing percutaneous coronary intervention
Atrial fibrillation
Meta-Analysis Comparing Potent Oral P2Y12 Inhibitors versus Clopidogrel in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
The WOEST 2 registry : A prospective registry on antithrombotic therapy in atrial fibrillation patients undergoing percutaneous coronary intervention
How cardiologists manage antithrombotic treatment of patients with atrial fibrillation undergoing percutaneous coronary stenting: the WOEST survey 2018
Anti-thrombotic strategies in patients with atrial fibrillation undergoing PCI
Atrial remodeling in atrial fibrillation and association between microRNA network and atrial fibrillation
Low on-clopidogrel ADP- and TRAP-6-induced platelet aggregation in patients with atrial fibrillation undergoing percutaneous coronary intervention: an observational pilot study
Low on-clopidogrel ADP- and TRAP-6-induced platelet aggregation in patients with atrial fibrillation undergoing percutaneous coronary intervention: an observational pilot study
Left atrial appendage closure in nonvalvular atrial fibrillation patients with percutaneous coronary intervention
Optimal antithrombotic treatment of patients with atrial fibrillation undergoing percutaneous coronary intervention: triple therapy is too much!
Novel Dual Therapy: A Paradigm Shift in Anticoagulation in Patients of Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
Antithrombotic treatment in atrial fibrillation patients needing percutaneous coronary intervention
Atrial fibrillation
Meta-Analysis Comparing Potent Oral P2Y12 Inhibitors versus Clopidogrel in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
The WOEST 2 registry : A prospective registry on antithrombotic therapy in atrial fibrillation patients undergoing percutaneous coronary intervention
How cardiologists manage antithrombotic treatment of patients with atrial fibrillation undergoing percutaneous coronary stenting: the WOEST survey 2018
Anti-thrombotic strategies in patients with atrial fibrillation undergoing PCI